OnDemand WTP Pricing Research

States Call for Transparency From PBMs Following Report About Spread Pricing | BioSpace

Days after a Scripps Research study supported the argument that the rebate system controlled in part by Pharmacy Benefits Managers (PBMs) has led to an increase in higher drug prices, some state governments are now moving toward greater regulation of the industry.

Massachusetts and some other states are pursuing action to increase oversight of PBMs to ensure that state money used on medications is spent efficiently at all points in the drug distribution chain. An analysis from the state’s Health Policy Commission shows how much prescription drug spending is impacting Massachusetts. In 2017, total prescription drug spending at pharmacies grew 4.1% in Massachusetts, the commission’s report showed. Over the course of five years, from 2012 to 2017, MassHealth prescription drug spending nearly doubled from $1.1 billion to $1.9 billion.

Read complete article here:

States Call for Transparency From PBMs Following Report About Spread Pricing | BioSpace.

Post a Comment

WP-SpamFree by Pole Position Marketing